baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

CSL LTD/ AU000000CSL8 /

14/06/2024 09:08:38	Chg. -0.0400	Volume	Bid11:55:55	Ask11:55:55	Market Capitalization	Dividend Y.	P/E Ratio
176.9000EUR	-0.02%	0 Turnover: 0.0000	178.5000Bid Size: 100	181.7000Ask Size: 100	86.27 bill.EUR	-	-

GlobeNewswire 31/05 Immuron Board Changes

GlobeNewswire 22/05 Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...

GlobeNewswire 13/05 Cara Therapeutics Reports First Quarter 2024 Financial Results

GlobeNewswire 09/05 ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Re...

GlobeNewswire 08/05 Carlyle Secured Lending, Inc. Announces Financial Results For First Quarter Ended 2024, Declares Sec...

GlobeNewswire 07/05 uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

GlobeNewswire 07/05 Uniti Group Inc. Announces Pricing of Senior Secured Notes Offering

GlobeNewswire 06/05 Travere Therapeutics Reports First Quarter 2024 Financial Results

GlobeNewswire 06/05 Uniti Group Inc. Announces Private Offering of Senior Secured Notes

GlobeNewswire 01/05 Amarin Reports First Quarter 2024 Business Update and Financial Results

GlobeNewswire 30/04 EU Nephrologists Foresee Travere/CSL Vifor’s FILSPARITM (sparsentan) Transforming IgA Nephropathy Tr...

GlobeNewswire 30/04 Mark Cuban Foundation and CSL Bring AI Bootcamp to Philadelphia Teens

GlobeNewswire 30/04 ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Ap...

GlobeNewswire 24/04 Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...

GlobeNewswire 16/04 Eureka Shipping Announces Construction of New Cutting-Edge Cement Carrier for Great Lakes Trade

GlobeNewswire 11/03 4BIO Capital Strengthens Advisory Board and Investment Team

GlobeNewswire 11/03 Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administrat...

GlobeNewswire 06/03 Kamada Issues 2024 CEO Letter to Shareholders

GlobeNewswire 04/03 Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire 04/03 Carlyle Secured Lending, Inc. Names Justin Plouffe CEO and Member of the Board of Directors

GlobeNewswire 28/02 uniQure Announces 2023 Financial Results and Highlights Recent Company Progress

GlobeNewswire 26/02 Carlyle Secured Lending, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results, Increas...

GlobeNewswire 23/02 Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...

GlobeNewswire 15/02 Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire 23/01 CSL Recognized as Top Employer for Young People for Third Consecutive Year

CSL LTD/ AU000000CSL8 /

If you wish to receive reply to your feedback, please provide your email address.